Scientists at Tokyo Institute of Technology have developed a portable and wearable terahertz scanning device for non-invasive inspection of three-dimensional objects. The device is made using arrays of carbon nanotubes and does not require bulky peripheral optical components.
The primary goal of any healthcare provider is to improve the lives of patients through effective treatment. However, because they are also businesses, hospitals have concerns that entail much more than this. To be viable in the long term, hospitals must manage their margins to fund their mission.
LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow System designed for venous arterialization of the lower limbs in end-stage patients at risk of limb amputation for critical limb ischemia (CLI).
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
St. Jude Medical Inc. announced results of the MOMENTUM 3 U.S. IDE Clinical Study during a late-breaking clinical trial session at the American Heart Association (AHA) Scientific Sessions, Nov. 12-16 in New Orleans. The MOMENTUM 3 study compared the HeartMate 3 Left Ventricular Assist System (LVAS) to the HeartMate II LVAS in treating advanced stage heart failure, and is the largest LVAD trial in the world to evaluate both short-term and long-term patients in a single study. The study results demonstrated patients receiving the HeartMate 3 LVAS had an 86.2 percent survival rate with freedom from disabling stroke and reoperation to repair or replace the device.
Corsens Medical Ltd. announced that it has received clearance for a Pre-Marketing Notification (510(k)) with the U.S. Food and Drug Administration (FDA) for its Corsens Cardiac Monitor (patents pending).
Shimadzu's latest generation interventional lab angiography imaging system, the Trinias, enables advanced imaging ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 7, 2016 — Boston Scientific announced a definitive agreement to acquire certain manufacturing assets and ...
December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substantial ...
December 7, 2016 — Abiomed Inc. announced it has expanded its U.S. Food and Drug Administration (FDA) pre-market ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 7, 2016 — Teleflex Inc. and Vascular Solutions Inc. announced that the companies have entered into a definitive ...
December 7, 2016 — At the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America ...
December 6, 2016 — The Spectranetics Corp. announced in late November that its Stellarex 0.014-inch drug-coated ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Researchers at Princess Alexandra Hospital, Brisbane, Australia, have demonstrated that cardiac amyloidosis (abnormal deposits of proteins in the heart), which is notoriously difficult to diagnose, can be visualized noninvasively with positron emission tomography (PET) using the radiotracer fluorine-18 (F-18)-florbetaben. The study is published in the November issue of The Journal of Nuclear Medicine.
December 5, 2016 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional ...
Sectra announced that nonprofit healthcare system ProMedica is adding the Sectra Cardiology Module into its existing enterprise imaging architecture. Through integration with the Epic Cupid reporting module, physicians will have combined access to their patients’ complete imaging history for both radiology and cardiology.